共 24 条
Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care
被引:31
作者:
Suarez-del-Real, Yolanda
[2
]
Allende-Perez, Silvia
[2
]
Alferez-Mancera, Araceli
[2
]
Bertha Rodriguez, Rosa
[2
]
Jimenez-Toxtle, Silvia
[3
]
Mohar, Alejandro
[4
]
Onate-Ocana, Luis F.
[1
]
机构:
[1] Inst Nacl Cancerol, Dept Gastroenterol, Mexico City 14080, DF, Mexico
[2] Inst Nacl Cancerol, Unidad Soporte Paliac & Dolor Canc, Mexico City 14080, DF, Mexico
[3] Inst Nacl Cancerol, Dept Trabajo Social, Mexico City 14080, DF, Mexico
[4] Inst Nacl Cancerol, Unidad Invest Biomed Canc, Mexico City 14080, DF, Mexico
关键词:
palliative care;
health-related quality of life;
end of life;
EORTC;
CANCER-PATIENTS;
QLQ-C30;
D O I:
10.1002/pon.1801
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background: Health-related quality of life (HRQL) is an important outcome in oncology, particularly in the palliative care setting. The European Organization for Research and Treatment of Cancer (EORTC) QLQ-C15-PAL questionnaire is a brief version of QLQ-C30. Our aim is to validate the Mexican-Spanish version of the QLQ-C15-PAL questionnaire to measure HRQL in patients with terminal cancer. Methods: Consecutive patients with biopsy proven cancer were included in the study. All were treated in a cancer center in Mexico and were referred for palliative care because of far-advanced, recurrent or metastatic cancer. QLQ-C15-PAL questionnaire was applied in the first visit to the Unit and palliative care was offered to all patients depending on their specific necessities. Results: Eighty-three patients were enrolled in this study (mean age, 61.2 years). Compliance rates were high; all patients completed to the questionnaire in <20 min and the instrument was well-received. Five missing values in five different items were found. QLQ-C15 scales distinguished between other clinically distinct groups of patients. Multi-trait scaling analysis demonstrated good convergent and discriminant validity. Cronbach's alpha coefficients were >0.7 in three of four multi-item scales (0.67 in the fourth). Test-retest scores were consistent in some scales, while improve or worsen in others. Better Global health, Dyspnea, Insomnia, Fatigue and Appetite scales were associated with longer survival. Conclusion: The Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire is reliable and valid for HRQL measurement in patients with terminal cancer, and is appropriate for use in clinical trials of Mexican patients. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:889 / 896
页数:8
相关论文